• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病(NAFLD)的新见解和潜在治疗方法:CYP2E1 和类黄酮。

New insight and potential therapy for NAFLD: CYP2E1 and flavonoids.

机构信息

State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.

State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China; College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.

出版信息

Biomed Pharmacother. 2021 May;137:111326. doi: 10.1016/j.biopha.2021.111326. Epub 2021 Feb 5.

DOI:10.1016/j.biopha.2021.111326
PMID:33556870
Abstract

Over the years, the prevalence of nonalcoholic fatty liver disease (NAFLD) has increased year by year; however, due to its complicated pathogenesis, there is no effective treatment so far. It is reported that Cytochrome P450 2E1 (CYP2E1) plays an indispensable role in the development of NAFLD, and numerous studies have shown that flavonoids have a hepatoprotective effect and can exert a beneficial effect on NAFLD by regulating the activity of CYP2E1. Therefore, flavonoids may become effective drugs for the treatment of NAFLD in the future. This prompted us to review the research progress of the pathological mechanism of NAFLD and the impact of CYP2E1 activity changes during the pathological process, and to summarize the protective effect of flavonoids against CYP2E1 activity.

摘要

近年来,非酒精性脂肪性肝病(NAFLD)的患病率逐年上升;然而,由于其发病机制复杂,目前尚无有效的治疗方法。据报道,细胞色素 P450 2E1(CYP2E1)在 NAFLD 的发展中起着不可或缺的作用,大量研究表明,类黄酮具有保肝作用,并通过调节 CYP2E1 的活性对 NAFLD 发挥有益作用。因此,类黄酮类化合物将来可能成为治疗 NAFLD 的有效药物。这促使我们回顾了 NAFLD 的病理机制研究进展和病理过程中 CYP2E1 活性变化的影响,并总结了类黄酮对 CYP2E1 活性的保护作用。

相似文献

1
New insight and potential therapy for NAFLD: CYP2E1 and flavonoids.非酒精性脂肪性肝病(NAFLD)的新见解和潜在治疗方法:CYP2E1 和类黄酮。
Biomed Pharmacother. 2021 May;137:111326. doi: 10.1016/j.biopha.2021.111326. Epub 2021 Feb 5.
2
Hepatoprotective Effect of Loquat Leaf Flavonoids in PM-Induced Non-Alcoholic Fatty Liver Disease via Regulation of IRs-1/Akt and CYP2E1/JNK Pathways.枇杷叶黄酮通过调节 IRS-1/Akt 和 CYP2E1/JNK 通路对 PM 诱导的非酒精性脂肪肝病的保护作用。
Int J Mol Sci. 2018 Oct 1;19(10):3005. doi: 10.3390/ijms19103005.
3
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).吡格列酮、槲皮素和羟基柠檬酸对实验性诱导的非酒精性脂肪性肝炎(NASH)中细胞色素P450 2E1(CYP2E1)酶水平的影响。
Eur Rev Med Pharmacol Sci. 2014;18(18):2736-41.
4
Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.芪味铁屑胶囊通过调控 LXRα、PPARγ、NF-κB-iNOS-NO 信号通路对 3T3-L1 脂肪细胞及非酒精性脂肪性肝病大鼠的保护作用及机制研究。
J Ethnopharmacol. 2019 May 23;236:316-325. doi: 10.1016/j.jep.2019.03.006. Epub 2019 Mar 6.
5
Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling.基因型通过 Wnt/β-catenin-Cyp2e1 信号通路影响非酒精性脂肪性肝病的个体易感性和水飞蓟宾的治疗反应。
Int J Biol Sci. 2021 Sep 21;17(14):3936-3953. doi: 10.7150/ijbs.63732. eCollection 2021.
6
Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.儿童非酒精性脂肪性肝病及其亚型中的肝脂质过氧化和细胞色素 P-450 2E1。
J Clin Gastroenterol. 2011 Oct;45(9):800-7. doi: 10.1097/MCG.0b013e31821377e4.
7
Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition.枇杷(Eriobotrya japonica)叶中的总倍半萜糖苷通过抑制细胞色素P450 2E1减轻高脂饮食诱导的非酒精性脂肪性肝病。
Biomed Pharmacother. 2017 Jul;91:229-237. doi: 10.1016/j.biopha.2017.04.056. Epub 2017 Apr 28.
8
TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.细胞色素P450 2E1(CYP2E1)基因中rs2070673的TA等位基因与经活检证实的非酒精性脂肪性肝病患者的小叶炎症和非酒精性脂肪性肝炎相关。
J Gastroenterol Hepatol. 2021 Oct;36(10):2925-2934. doi: 10.1111/jgh.15554. Epub 2021 Jun 6.
9
Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.芡实种皮提取物通过增加IRS-1和抑制CYP2E1对高脂饮食诱导的小鼠非酒精性脂肪性肝病的肝保护作用。
J Oleo Sci. 2019 Jun 6;68(6):581-589. doi: 10.5650/jos.ess19018. Epub 2019 May 16.
10
Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.细胞色素P450 2E1(CYP2E1)在酒精及非酒精性物质所致线粒体功能障碍和肝损伤中的作用
Curr Mol Pharmacol. 2017;10(3):207-225. doi: 10.2174/1874467208666150817111114.

引用本文的文献

1
Effects of Soy Protein on Liver and Adipose Tissue Inflammation and Gut Microbiota in Mice Fed with Ketogenic Diets.大豆蛋白对生酮饮食喂养小鼠肝脏和脂肪组织炎症及肠道微生物群的影响。
Nutrients. 2025 Jul 25;17(15):2428. doi: 10.3390/nu17152428.
2
Clinical Insights into Non-Alcoholic Fatty Liver Disease and the Therapeutic Potential of Flavonoids: An Update.非酒精性脂肪性肝病的临床见解及黄酮类化合物的治疗潜力:最新进展
Nutrients. 2025 Mar 9;17(6):956. doi: 10.3390/nu17060956.
3
The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease.
E3泛素连接酶和去泛素化酶在代谢功能障碍相关脂肪性肝病中的新作用
J Transl Med. 2025 Mar 25;23(1):368. doi: 10.1186/s12967-025-06255-2.
4
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.新型 SNP-6 系列化合物的混合活性代谢物可改善代谢功能障碍相关的脂肪性肝炎和纤维化:临床前和临床试验的可喜结果。
J Transl Med. 2024 Oct 14;22(1):936. doi: 10.1186/s12967-024-05686-7.
5
Dietary inflammatory index and the risks of non-alcoholic fatty liver disease: a systematic review and meta-analysis.饮食炎症指数与非酒精性脂肪性肝病风险:一项系统评价和荟萃分析
Front Nutr. 2024 Jul 25;11:1388557. doi: 10.3389/fnut.2024.1388557. eCollection 2024.
6
Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review.解读细胞色素P450酶在代谢与疾病中的作用:全面综述
Biomedicines. 2024 Jul 2;12(7):1467. doi: 10.3390/biomedicines12071467.
7
From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients.从肠道到肝脏:揭示非酒精性脂肪性肝病(NAFL)和非酒精性脂肪性肝炎(NASH)患者肠道微生物群的差异
Front Microbiol. 2024 Apr 4;15:1366744. doi: 10.3389/fmicb.2024.1366744. eCollection 2024.
8
The role of the cytochrome P450 superfamily in the skin.细胞色素 P450 超家族在皮肤中的作用。
Expert Rev Mol Med. 2024 Apr 15;26:e15. doi: 10.1017/erm.2024.5.
9
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease.利福昔明对代谢功能障碍相关脂肪性肝病继发肝细胞癌动物模型表观遗传学和自噬的影响
World J Hepatol. 2024 Jan 27;16(1):75-90. doi: 10.4254/wjh.v16.i1.75.
10
Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults.不同来源的膳食维生素 A 摄入与成年人非酒精性脂肪肝之间的关系。
Sci Rep. 2024 Jan 22;14(1):1851. doi: 10.1038/s41598-024-52077-5.